U.S., Aug. 13 -- An application to own the trademark for 'AIM' has been filed on Feb. 07, 2020.
Owner(s):
AIM ImmunoTech Inc.; , 2117 SW Highway 484, FLORIDA
Goods and/or Services:
For: Intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of injuries resulting from surgery, thermal accidents or burns; Interferons; Parenterally administered interferon for use in treating viral diseases, immunological disorders and cancer; Pharmaceutical products, namely, pharmaceutical preparations for treatment of viral and infectious diseases, cancer, imm...